209 related articles for article (PubMed ID: 21737551)
1. Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis.
Mubarak KK; Montes-Worboys A; Regev D; Nasreen N; Mohammed KA; Faruqi I; Hensel E; Baz MA; Akindipe OA; Fernandez-Bussy S; Nathan SD; Antony VB
Eur Respir J; 2012 Jan; 39(1):133-40. PubMed ID: 21737551
[TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis.
Karki S; Surolia R; Hock TD; Guroji P; Zolak JS; Duggal R; Ye T; Thannickal VJ; Antony VB
FASEB J; 2014 Mar; 28(3):1122-31. PubMed ID: 24265486
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between pleural mesothelial cell and lung fibroblast contributes to pulmonary fibrosis.
Liu F; Yu F; Lu YZ; Cheng PP; Liang LM; Wang M; Chen SJ; Huang Y; Song LJ; He XL; Xiong L; Xin JB; Ma WL; Ye H
Biochim Biophys Acta Mol Cell Res; 2020 Nov; 1867(11):118806. PubMed ID: 32739525
[TBL] [Abstract][Full Text] [Related]
4. Bleomycin induced epithelial-mesenchymal transition (EMT) in pleural mesothelial cells.
Chen LJ; Ye H; Zhang Q; Li FZ; Song LJ; Yang J; Mu Q; Rao SS; Cai PC; Xiang F; Zhang JC; Su Y; Xin JB; Ma WL
Toxicol Appl Pharmacol; 2015 Mar; 283(2):75-82. PubMed ID: 25595642
[TBL] [Abstract][Full Text] [Related]
5. Antifibrotic role of αB-crystallin inhibition in pleural and subpleural fibrosis.
Bellaye PS; Burgy O; Colas J; Fabre A; Marchal-Somme J; Crestani B; Kolb M; Camus P; Garrido C; Bonniaud P
Am J Respir Cell Mol Biol; 2015 Feb; 52(2):244-52. PubMed ID: 25032514
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition.
Milara J; Navarro R; Juan G; Peiró T; Serrano A; Ramón M; Morcillo E; Cortijo J
Thorax; 2012 Feb; 67(2):147-56. PubMed ID: 22106015
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis.
Leppäranta O; Pulkkinen V; Koli K; Vähätalo R; Salmenkivi K; Kinnula VL; Heikinheimo M; Myllärniemi M
Am J Respir Cell Mol Biol; 2010 May; 42(5):626-32. PubMed ID: 19597127
[TBL] [Abstract][Full Text] [Related]
8. Pleural mesothelial cell differentiation and invasion in fibrogenic lung injury.
Zolak JS; Jagirdar R; Surolia R; Karki S; Oliva O; Hock T; Guroji P; Ding Q; Liu RM; Bolisetty S; Agarwal A; Thannickal VJ; Antony VB
Am J Pathol; 2013 Apr; 182(4):1239-47. PubMed ID: 23399488
[TBL] [Abstract][Full Text] [Related]
9. [A role for mesothelial cells in the genesis of idiopathic pulmonary fibrosis?].
Decologne N; Wettstein G; Bonniaud P
Bull Acad Natl Med; 2010 Feb; 194(2):383-9. PubMed ID: 21166126
[TBL] [Abstract][Full Text] [Related]
10. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.
Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL
Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417
[TBL] [Abstract][Full Text] [Related]
11. Myocardin Is Involved in Mesothelial-Mesenchymal Transition of Human Pleural Mesothelial Cells.
Tucker T; Tsukasaki Y; Sakai T; Mitsuhashi S; Komatsu S; Jeffers A; Idell S; Ikebe M
Am J Respir Cell Mol Biol; 2019 Jul; 61(1):86-96. PubMed ID: 30605348
[TBL] [Abstract][Full Text] [Related]
12. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
[TBL] [Abstract][Full Text] [Related]
13. The pleural mesothelium and transforming growth factor-β
Sacreas A; von der Thüsen JH; van den Bosch TPP; Weynand B; Verbeken EK; Debbaut C; Van Raemdonck DE; Vos R; Verleden SE
J Heart Lung Transplant; 2019 May; 38(5):570-579. PubMed ID: 30819647
[TBL] [Abstract][Full Text] [Related]
14. The hedgehog system machinery controls transforming growth factor-β-dependent myofibroblastic differentiation in humans: involvement in idiopathic pulmonary fibrosis.
Cigna N; Farrokhi Moshai E; Brayer S; Marchal-Somme J; Wémeau-Stervinou L; Fabre A; Mal H; Lesèche G; Dehoux M; Soler P; Crestani B; Mailleux AA
Am J Pathol; 2012 Dec; 181(6):2126-37. PubMed ID: 23031257
[TBL] [Abstract][Full Text] [Related]
15. The pleural mesothelium in development and disease.
Batra H; Antony VB
Front Physiol; 2014; 5():284. PubMed ID: 25136318
[TBL] [Abstract][Full Text] [Related]
16. Dickkopf proteins influence lung epithelial cell proliferation in idiopathic pulmonary fibrosis.
Pfaff EM; Becker S; Günther A; Königshoff M
Eur Respir J; 2011 Jan; 37(1):79-87. PubMed ID: 20650998
[TBL] [Abstract][Full Text] [Related]
17. Cysteine-rich protein 1 is regulated by transforming growth factor-β1 and expressed in lung fibrosis.
Järvinen PM; Myllärniemi M; Liu H; Moore HM; Leppäranta O; Salmenkivi K; Koli K; Latonen L; Band AM; Laiho M
J Cell Physiol; 2012 Jun; 227(6):2605-12. PubMed ID: 21882188
[TBL] [Abstract][Full Text] [Related]
18. VEGF/Src signaling mediated pleural barrier damage and increased permeability contributes to subpleural pulmonary fibrosis.
Lu YZ; Liang LM; Cheng PP; Xiong L; Wang M; Song LJ; Yu F; He XL; Xiong L; Wang XR; Xin JB; Ye H; Ma WL
Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L990-L1004. PubMed ID: 33787325
[TBL] [Abstract][Full Text] [Related]
19. Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression.
Ramos C; Montaño M; García-Alvarez J; Ruiz V; Uhal BD; Selman M; Pardo A
Am J Respir Cell Mol Biol; 2001 May; 24(5):591-8. PubMed ID: 11350829
[TBL] [Abstract][Full Text] [Related]
20. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
